FDA Inspection 1175407 — Gemini Pharmaceuticals, Inc.
The FDA completed an inspection of Gemini Pharmaceuticals, Inc. on July 26, 2022 in Commack, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Commack, NY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15869 | 21 CFR 111.75(c) | Specifications met - verify; finished batch |